An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor positive breast cancer. Chandarlapaty S, Dickler MN, Perez Fidalgo JA, Villanueva-Vazquez R, et al. Clin Cancer Res 2023 Jun 1:CCR-23-0011. doi: 10.1158/1078-0432.CCR-23-0011.

Read + Share

Amedeo Smart

Independent Medical Education

Chandarlapaty S, Dickler MN, Perez Fidalgo JA, Villanueva-Vazquez R, et al. An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor positive breast cancer. Clin Cancer Res 2023 Jun 1:CCR-23-0011. doi: 10.1158/1078-0432.CCR-23-0011.
PMID: 37261814